MARK ZOBECK to Adolescent
This is a "connection" page, showing publications MARK ZOBECK has written about Adolescent.
Connection Strength
0.342
-
Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers. JCO Precis Oncol. 2025 Feb; 9:e2400556.
Score: 0.060
-
Diagnostic BMI and Induction Therapy Weight Change Associated With Hepatotoxicity in Pediatric Patients With Acute Lymphoblastic Leukemia. Cancer Med. 2026 Sep; 15(9):e72218.
Score: 0.017
-
Baseline Risk of Treatment Abandonment and Survival of Children With Common and Curable Cancers in the Zero Abandonment Cash Transfer Programme-A Multi-Centre Prospective CANCaRe Africa Study. Pediatr Blood Cancer. 2026 Oct; 73(10):e70621.
Score: 0.017
-
Admixture Mapping Reveals Candidate Regions for Methotrexate Neurotoxicity Susceptibility: A Reducing Disparities in Acute Leukemia Consortium Report. Pediatr Blood Cancer. 2026 Oct; 73(10):e70554.
Score: 0.017
-
Venous Thromboembolism in Pediatric Bone Sarcoma Patients: A 10-Year, Single-Institution Experience Encompassing the COVID-19 Pandemic. Pediatr Blood Cancer. 2026 Aug; 73(8):e70390.
Score: 0.016
-
Marrow-ablative chemotherapy and re-irradiation are associated with improved overall survival in patients with relapsed central nervous system nongerminomatous germ cell tumors. J Neurooncol. 2026 Apr 17; 177(3).
Score: 0.016
-
Predicting development of pediatric chronic immune thrombocytopenia at disease onset using a statistical risk model. Blood. 2026 04 16; 147(16):1863-1872.
Score: 0.016
-
Incidence of Cancers Among Children Living With HIV in Malawi After Widespread Availability of Antiretroviral Therapy: A Population-Based Study. JCO Glob Oncol. 2026 Mar; 12(3):e2500448.
Score: 0.016
-
Relapse patterns among children and adolescents with Kaposi sarcoma in Malawi. Pediatr Hematol Oncol. 2025 Aug; 42(5):276-286.
Score: 0.015
-
The impact of genetic ancestry on survival outcomes in pediatric rhabdomyosarcoma: A report from the Children's Oncology Group. HGG Adv. 2025 Jul 10; 6(3):100466.
Score: 0.015
-
Prediction of methotrexate neurotoxicity using clinical, sociodemographic, and area-based information in children with acute lymphoblastic leukemia. Oncologist. 2025 Jun 04; 30(6).
Score: 0.015
-
Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia. Pharmacotherapy. 2025 01; 45(1):4-11.
Score: 0.015
-
Delayed excretion of high-dose methotrexate in pediatric acute leukemia correlates with laxative and constipation management. Pediatr Blood Cancer. 2025 Jan; 72(1):e31377.
Score: 0.015
-
Immunoglobulins act as predictors of chronicity in pediatric immune thrombocytopenia. Blood Adv. 2024 10 08; 8(19):5118-5121.
Score: 0.015
-
Cerebral Sinus Venous Thrombosis in Pediatric Acute Lymphoblastic Leukemia: Incidence, Clinical Characteristics, and Long-term Neurologic Outcomes. J Child Neurol. 2024 11; 39(13-14):494-499.
Score: 0.015
-
Episodes of acute methotrexate-related neurotoxicity linked to compromised long-term neurocognitive function. Pediatr Blood Cancer. 2024 09; 71(9):e31169.
Score: 0.014
-
Initial von Willebrand factor antigen values in adolescent females predict future values. Haemophilia. 2023 Nov; 29(6):1547-1555.
Score: 0.014
-
Adolescent acquired thrombotic thrombocytopenic purpura: An analysis of the Pediatric Health Information System database. Thromb Res. 2023 02; 222:63-67.
Score: 0.013
-
Pediatric rhabdomyosarcoma incidence and survival in the United States: An assessment of 5656 cases, 2001-2017. Cancer Med. 2023 02; 12(3):3644-3656.
Score: 0.013
-
Hispanic ethnicity is associated with prolonged clearance of high dose methotrexate and severe nephrotoxicity in children and adolescents with acute lymphoblastic leukemia. Leuk Lymphoma. 2020 11; 61(11):2771-2774.
Score: 0.011